Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
Med Oncol. 2022 Sep 7;39(12):187. doi: 10.1007/s12032-022-01789-7.
Cancer and coronary artery disease (CAD) are two of the most common causes of death, and they frequently coexist, especially as the world's population ages. CAD can develop prior to or following cancer diagnosis, as well as a side effect of cancer treatment. CAD develops as complex interactions of lifestyle and hereditary variables, just like the development of the most complex and non-communicable diseases. Cancer is caused by both external/acquired factors (tobacco, food, physical activity, alcohol consumption, epigenetic alterations) and internal/inherited factors (genetic mutations, hormones, and immunological diseases). The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (Cas9) system has recently emerged as a strong tool for gene therapy for both cancer as well as CAD treatment due to its great accuracy and efficiency. A deeper understanding of the complex link between CAD and cancer should lead to better prevention, faster detection, and safer treatment strategies.
癌症和冠状动脉疾病(CAD)是两种最常见的死亡原因,它们经常同时存在,尤其是随着世界人口的老龄化。CAD 可以在癌症诊断之前或之后发展,也可以是癌症治疗的副作用。CAD 的发展是生活方式和遗传变量的复杂相互作用的结果,就像最复杂和非传染性疾病的发展一样。癌症是由外部/获得性因素(烟草、食物、体力活动、酒精摄入、表观遗传改变)和内部/遗传性因素(基因突变、激素和自身免疫性疾病)引起的。簇状规则间隔短回文重复(CRISPR)相关蛋白 9(Cas9)系统由于其高度的准确性和效率,最近成为癌症和 CAD 治疗基因治疗的有力工具。对 CAD 和癌症之间复杂联系的更深入了解应导致更好的预防、更快的检测和更安全的治疗策略。